Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM
-
Number of holders
-
41
-
Total 13F shares, excl. options
-
17,262,299
-
Shares change
-
+17,262,299
-
Total reported value, excl. options
-
$297,816,000
-
Value change
-
+$297,816,030
-
Number of buys
-
41
-
Price
-
$17.35
Significant Holders of Kiniksa Pharmaceuticals Intern - COM (KNSA) as of Q2 2018
41 filings reported holding KNSA - Kiniksa Pharmaceuticals Intern - COM as of Q2 2018.
Kiniksa Pharmaceuticals Intern - COM (KNSA) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17,262,299 shares
.
Largest 10 shareholders include Hillhouse Capital Management, Ltd. (5,736,527 shares), BAKER BROS. ADVISORS LP (3,000,000 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1,226,890 shares), BOXER CAPITAL, LLC (1,172,700 shares), Sofinnova Ventures Inc (922,700 shares), FMR LLC (903,392 shares), Cormorant Asset Management, LP (831,000 shares), AMERIPRISE FINANCIAL INC (722,291 shares), VHCP Management II, LLC (639,230 shares), and EVENTIDE ASSET MANAGEMENT, LLC (296,400 shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.